Methadone in post-herpetic neuralgia: A pilot proofof- concept study

Clinics

Volumn 68, Issue 7, 2013, Pages 1057-1060

  Teixeira, Manoel J ^a   Okada, Massako ^a   Cueva Moscoso, Ana Sofia ^a   Takahashi Puerta, Mariana Yumi ^a   Yeng, Lin T ^a   Galhardoni, Ricardo ^a   Tengan, Sérgio ^a   de Andrade, Daniel Ciampi ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Methadone; Neuropathic pain; Post herpetic neuralgia

Indexed keywords

METHADONE; NARCOTIC ANALGESIC AGENT;

AGED; ARTICLE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; FEMALE; HUMAN; MALE; MIDDLE AGED; PILOT STUDY; POSTHERPETIC NEURALGIA; RANDOMIZED CONTROLLED TRIAL; TIME; TREATMENT OUTCOME; VERY ELDERLY; VISUAL ANALOG SCALE;

AGED; AGED, 80 AND OVER; ANALGESICS, OPIOID; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; METHADONE; MIDDLE AGED; NEURALGIA, POSTHERPETIC; PILOT PROJECTS; TIME FACTORS; TREATMENT OUTCOME; VISUAL ANALOG SCALE;

EID: 84881049808     PISSN: 18075932     EISSN: None     Source Type: Journal    
DOI: 10.6061/clinics/2013(07)25     Document Type: Article

References (21)

1. Bouhassira D, Lanteri-Minet M, Attal N, Laurent B, Touboul C. Prevalence of chronic pain with neuropathic characteristics in the general population. Pain. 2008;136(3):380-7, http://dx.doi.org/10.1016/j. pain.2007.08.013.
2. Treede RD, Jensen TS, Campbell JN, Cruccu G, Dostrovsky JO, Griffin JW, et al. Neuropathic pain: redefinition and a grading system for clinical and research purposes. Neurology. 2008;70(18):1630-5, http://dx.doi. org/10.1212/01.wnl.0000282763.29778.59.
3. Breivik EK, Bjornsson GA, Skovlund E. A comparison of pain rating scales by sampling from clinical trial data. Clin J Pain. 2000;16(1):22-8.
4. Daut RL, Cleeland CS, Flanery RC. Development of the Wisconsin Brief Pain Questionnaire to assess pain in cancer and other diseases. Pain. 1983;17(2):197-210, http://dx.doi.org/10.1016/0304-3959(83)90143-4.
5. Pimenta C, Teixeira M. Questionário de Dor McGill: proposta de adaptação para a língua portuguesa. Rev Esc Enf USP. 1996;30(3):473-83.
6. Dell RB, Holleran S, Ramakrishnan R. Sample size determination. Ilar J. 2002;43(4):207-13, http://dx.doi.org/10.1093/ilar.43.4.207.
7. Morley JS, Bridson J, Nash TP, Miles JB, White S, Makin MK. Low-dose methadone has an analgesic effect in neuropathic pain: a double-blind randomized controlled crossover trial. Palliat Med. 2003;17(7):576-87, http://dx.doi.org/10.1191/0269216303pm815oa.
8. Moulin DE, Palma D, Watling C, Schulz V. Methadone in the management of intractable neuropathic noncancer pain. Can J Neurol Sci. 2005;32(3):340-3.
9. Watson CP. Methadone for neuropathic pain: a new use for an old drug? Can J Neurol Sci. 2005;32(3):271-2.
10. Terpening CM, Johnson WM. Methadone as an analgesic: a review of the risks and benefits. W V Med J. 2007;103(1):14-8.
11. Altier N, Dion D, Boulanger A, Choinière M. Managment of Chronic Neuropathic pain with methadone: A review of 13 cases. Clin J Pain. 2005;21:364-9.
12. Altier N, Dion D, Boulanger A, Choinière M. Sucessful use of methadone in the treatment of chronic neuropathic pain arising from burn injuries: a case-study. Burns. 2001;27:771-5, http://dx.doi.org/10.1016/S0305-4179(01)00032-8.
13. Cherny N. Is oral methadone better than placebo or other oral/ transdermal opioids in the management of pain? Palliat Med. 2011;25(5):488-93, http://dx.doi.org/10.1177/0269216310397687.
14. Ventafridda V, Ripamonti C, Bianchi M, Sbanotto A, De Conno F. A randomized study on oral administration of morphine and methadone in the treatment of cancer pain. J Pain Symptom Manage. 1986;1(4):203-7, http://dx.doi.org/10.1016/S0885-3924(86)80042-2.
15. Gourlay GK, Cherry DA, Cousins MJ. A comparative study of the efficacy and pharmacokinetics of oral methadone and morphine in the treatment of severe pain in patients with cancer. Pain. 1986;25(3):297-312, http://dx.doi.org/10.1016/0304-3959(86)90234-4.
16. Bruera E, Palmer JL, Bosnjak S, Rico MA, Moyano J, Sweeney C, et al. Methadone versus morphine as a first-line strong opioid for cancer pain: a randomized, double-blind study. J Clin Oncol. 2004;22(1):185-92.
17. Mercadante S, Porzio G, Ferrera P, Fulfaro F, Aielli F, Verna L, et al. Sustained-release oral morphine versus transdermal fentanyl and oral methadone in cancer pain management. Eur J Pain. 2008;12 (8):1040-6.
18. Erichsen HK, Hao JX, Xu XJ, Blackburn-Munro G. Comparative actions of the opioid analgesics morphine, methadone and codeine in rat models of peripheral and central neuropathic pain. Pain, 2005;116(3):347-58, http://dx.doi.org/10.1016/j.pain.2005.05.004.
19. Lemberg K, Kontinen VK, Viljakka K, Kylanlahti I, Yli-Kauhaluoma J, Kalso E. Morphine, oxycodone, methadone and its enantiomers in different models of nociception in the rat. Anesth Analg, 2006;102(6):1768-74, http://dx.doi.org/10.1213/01.ane.0000205751.88422.41.
20. Sotgiu ML, Valente M, Storchi R, Caramenti G, Biella GE. Cooperative N-methyl-D-aspartate (NMDA) receptor antagonism and mu-opioid receptor agonism mediate the methadone inhibition of the spinal neuron pain-related hyperactivity in a rat model of neuropathic pain. Pharmacol Res. 2009;60(4):284-90, http://dx.doi.org/10.1016/j.phrs. 2009.04.002.
21. Toombs JD, Kral LA. Methadone treatment for pain states. Am Fam Physician. 2005;71(7):1353-8.